Significant disparities in prognosis were observed among patients in different stages or grades, particularly those in pathologic T stages, including T1 and T2, T2 and T3, T3, histologic grade G3, pathologic stages I and II, and stages II and III, and among patients who were tumor-free or had tumors, as well as those in Child-Pugh grade A and had AFP levels less than 400 ng/ml (Figures 5A–J). Here, AFP is linked to neoplasm.